SAN FRANCISCO, May 9, 2025 /PRNewswire/ -- On May 1, 2025, investors in SelectQuote (NYSE: SLQT) saw the price of their shares tumble over 19% after the U.S. Department of Justice announced it had filed a lawsuit against the company, other insurance brokers, and three of the nation's largest health insurance companies, claiming violations of the False Claims Act.
Hagens Berman urges SelectQuote investors who suffered substantial losses to submit your losses now. The firm also encourages persons with knowledge who may be able to assist in the investigation to contact its attorneys.
Visit: www.hbsslaw.com/investor-fraud/slqt
SelectQuote (SLQT) Investigation:
The investigation is focused on the propriety of SelectQuote's disclosures concerning its sales and other business practices, particularly with respect to its Senior business which offers Medicare Advantage ("MA") plans written by health insurance companies such as Aetna, Anthem, and Humana ("insurers").
In the past, SelectQuote has claimed "[o]ur agents are trained to offer unbiased advice in order to be more aligned to the specific needs of each customer" and Senior "provides unbiased comparison shopping for Medicare Advantage ('MA') and Medicare Supplement ('MS') insurance plans[.]"
SelectQuote's claims came into question on May 1, 2025, when the DOJ filed a complaint alleging that from 2016 through at least 2021 the insurers:
Some of the world’s largest food manufacturers, including Nestlé and Unilever, are flooding the market with expensive dietary supplements that promise solutions to stress, obesity, and menopausal ...